HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Gérald Simonneau Selected Research

Idiopathic pulmonary hypertension

8/2015Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
7/2015Validation of two predictive models for survival in pulmonary arterial hypertension.
4/2014Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry.
2/2014Targeted therapies in pulmonary arterial hypertension.
2/2014Pulmonary arterial hypertension in familial hemiplegic migraine with ATP1A2 channelopathy.
1/2014EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.
7/2013Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study.
5/2013Estimating right ventricular stroke work and the pulsatile work fraction in pulmonary hypertension.
1/2013Definition and classification of pulmonary hypertension.
1/2013Pulmonary arterial hypertension.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Gérald Simonneau Research Topics

Disease

43Pulmonary Hypertension (Ayerza Syndrome)
01/2016 - 06/2002
9Heart Failure
02/2014 - 08/2002
9Systemic Scleroderma (Systemic Sclerosis)
06/2012 - 06/2007
8Connective Tissue Diseases (Connective Tissue Disease)
03/2014 - 08/2004
7Disease Progression
12/2015 - 05/2010
6Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary)
12/2015 - 07/2004
5HIV Infections (HIV Infection)
01/2010 - 12/2004
4Infection
11/2015 - 08/2005
4Fibrosis (Cirrhosis)
01/2014 - 12/2005
3Headache (Headaches)
12/2015 - 10/2008
3Pain (Aches)
12/2015 - 08/2004
3Hypertrophy
01/2014 - 09/2002
3Inflammation
01/2014 - 12/2005
3Lung Diseases (Lung Disease)
01/2013 - 02/2008
3Anoxia (Hypoxia)
01/2013 - 04/2009
3Neoplasms (Cancer)
10/2012 - 05/2011
3Heart Diseases (Heart Disease)
11/2008 - 06/2005
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2008 - 07/2006
2Nausea
12/2015 - 10/2008
2Diarrhea
12/2015 - 11/2005
2Sarcoidosis (Schaumann Disease)
11/2015 - 09/2010
2Portal Hypertension
12/2014 - 11/2008
2Anemia
08/2013 - 08/2003
2Venous Thromboembolism
07/2013 - 11/2011
2Pulmonary Embolism
07/2013 - 01/2007
2Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
11/2012 - 09/2010
2Pulmonary Edema
11/2012 - 07/2008
2Hyperplasia
08/2011 - 03/2002
2Rare Diseases (Rare Disease)
09/2009 - 05/2006
2Dyspepsia (Indigestion)
10/2008 - 11/2005
2Dyspnea (Shortness of Breath)
10/2008 - 08/2004
2Mixed Connective Tissue Disease (MCTD)
02/2008 - 07/2006
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2015
1Tuberculosis (Tuberculoses)
11/2015
1Syncope (Fainting)
03/2015
1Hypothermia
09/2014
1Channelopathies
02/2014
1Migraine with Aura (Familial Hemiplegic Migraine)
02/2014
1Right Ventricular Hypertrophy
01/2014
1Nasopharyngitis
08/2013
1Diabetes Mellitus
07/2013
1Subdural Hematoma (Subdural Hemorrhage)
03/2013
1Ascites
01/2013
1Acute Kidney Injury (Acute Renal Failure)
01/2013
1Hypertension (High Blood Pressure)
01/2013
1Edema
01/2013
1Low Cardiac Output
10/2012

Drug/Important Bio-Agent (IBA)

55Idiopathic pulmonary hypertensionIBA
08/2015 - 03/2002
10Epoprostenol (Prostacyclin)FDA LinkGeneric
12/2015 - 06/2002
8bosentan (Tracleer)FDA Link
01/2013 - 12/2004
5sildenafil (Viagra)FDA Link
09/2013 - 11/2005
5Endothelin Receptors (Endothelin Receptor)IBA
08/2009 - 12/2004
4ProstaglandinsIBA
03/2010 - 09/2002
3Carbon MonoxideIBA
01/2015 - 01/2010
3Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2011 - 06/2002
3Endothelins (Endothelin)IBA
09/2011 - 12/2004
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
12/2015 - 09/2006
2riociguatIBA
12/2015 - 05/2015
2N- (5- (4- bromophenyl)- 6- (2- (5- bromopyrimidin- 2- yloxy)ethoxy)pyrimidin- 4- yl)- N'- propylaminosulfonamideIBA
12/2015 - 08/2013
2imatinib (Gleevec)FDA Link
11/2015 - 03/2013
2MonocrotalineIBA
01/2014 - 01/2011
2AntibodiesIBA
06/2012 - 04/2012
2AutoantibodiesIBA
06/2012 - 09/2007
2Dexfenfluramine (Redux)IBA
10/2011 - 05/2008
2Vasodilator Agents (Vasodilators)IBA
02/2010 - 02/2008
2Phosphodiesterase 5 InhibitorsIBA
09/2009 - 09/2006
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2008 - 07/2006
2Immunosuppressive Agents (Immunosuppressants)IBA
02/2008 - 07/2006
12- (4- ((5,6- diphenylpyrazin- 2- yl)(isopropyl)amino)butoxy)- N- (methylsulfonyl)acetamideIBA
12/2015
1SolventsIBA
12/2015
1Protein Kinases (Protein Kinase)IBA
11/2015
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2015
1Mediastinal FibrosisIBA
11/2015
1Guanylate Cyclase (Guanylyl Cyclase)IBA
05/2015
1pro-brain natriuretic peptide (1-76)IBA
03/2015
1Alkylating AgentsIBA
02/2015
1Cyproterone AcetateIBA
06/2014
1Brain Natriuretic Peptide (Natrecor)FDA Link
03/2014
1HormonesIBA
03/2014
1Acetylcysteine (Siran)FDA LinkGeneric
01/2014
1Interleukin-6 (Interleukin 6)IBA
01/2014
1Blood Group Antigens (Blood Groups)IBA
07/2013
1DiureticsIBA
01/2013
1OxygenIBA
11/2012
1benfluorex (S 780)IBA
11/2012
1AngiotensinsIBA
10/2012
1ReninIBA
10/2012
1Losartan (Cozaar)FDA LinkGeneric
10/2012
1lipoarabinomannan (LAM)IBA
09/2012

Therapy/Procedure

7Lung Transplantation
01/2016 - 09/2002
7Endarterectomy (Thromboendarterectomy)
11/2014 - 09/2006
2Splenectomy
12/2015 - 08/2003
2Highly Active Antiretroviral Therapy (HAART)
01/2010 - 09/2008
1Off-Label Use
12/2015
1Angioplasty (Angioplasty, Transluminal)
12/2015
1Indwelling Catheters (Arterial Line)
12/2015
1Drug Therapy (Chemotherapy)
02/2015
1Cardiopulmonary Bypass (Heart-Lung Bypass)
09/2014
1Renal Replacement Therapy (Therapies, Renal Replacement)
01/2013
1Pneumonectomy (Lung Volume Reduction)
10/2012